
Edwards receives CE mark for Sapien M3 mitral valve replacement device
Dive Brief: Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the company said Monday. The device is designed for people with symptomatic mitral regurgitation who are unsuitable for surgery …